SML1385

Lomitapide

≥98% (HPLC)

• Synonym(e): AEGR-733, BMS-201038, N-(2,2,2-Trifluoroethyl)-9-[4-[4-[[[4′-(trifluoromethyl)[1,1′-biphenyl]2-yl]carbonyl]amino]-1-piperidinyl]butyl]9H-fluoren-9-carboxamde
• Empirische Formel (Hill-System): C₃₉H₃₇F₆N₃O₂
• CAS-Nummer: 182431-12-5
• Molekulargewicht: 693.72
• MDL-Nummer: MFCD16620494
• UNSPSC-Code: 51111800
• PubChem Substanz-ID: 329825833
• NACRES: NA.77

Eigenschaften

• Qualitätsniveau: 100
• Assay: ≥98% (HPLC)
• Form: powder
• Farbe: white to beige
• Löslichkeit: DMSO: 20 mg/mL, clear
• Lagertemp.: 2-8°C
• SMILES String: O=C(NCC(F)(F)F)C1(C(C=CC=C2)=C2C3=C1C=CC=C3)CCCCN(CC4)CCC4NC(C5=C(C6=CC=C(C(F)(F)F)C=C6)C=CC=C5)=O
• InChI: 1S/C39H37F6N3O2/c40-38(41,42)25-46-36(50)37(33-13-5-3-10-30(33)31-11-4-6-14-34(31)37)21-7-8-22-48-23-19-28(20-24-48)47-35(49)32-12-2-1-9-29(32)26-15-17-27(18-16-26)39(43,44)45/h1-6,9-18,28H,7-8,19-25H2,(H,46,50)(H,47,49)
• InChIKey: MBBCVAKAJPKAKM-UHFFFAOYSA-N
• Angaben zum Gen: human ... MTTP(4547) , P4HB(5034)

Beschreibung

Anwendung

Lomitapide has been used as a microsomal triglyceride transfer protein (MTP) inhibitor to study its effects on very-low-density lipoproteins (VLDL) export in mouse hepatocytes.[1]

Biochem./physiol. Wirkung

Lomitapide can lower the secretion of very-low-density lipoproteins (VLDL) and chylomicrons.[2]

Lomitapide is an inhibitor of microsomal triglyceride transfer protein (MTP).

Lomitapide is an inhibitor of microsomal triglyceride transfer protein (MTP). Lomitapide has been shown to be highly effective in reducing LDL-cholesterol and triglycerides, and has been aproved for treatment of homozygous familial hypercholesterolemia.

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable